Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Sector: Healthcare; Industry: Biotechnology

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. Iovance Biotherapeutics, Inc. has collaboration agreements with Moffitt, M.D. Anderson Cancer Center, Ohio State University, and MedImmune; and research collaboration with Cellectis S.A. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2018-12-13 MCPEAK MERRILL A Director Buy 10,000 $9.63 $96,273 No
2013-11-05 MCPEAK MERRILL A/ Director Buy 50,000 $2.00 $100,000 Yes
2011-07-21 MCPEAK MERRILL A/ Director Buy 10,000 $1.40 $14,000 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?